Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
USE OF EXENDINS AND AGONISTS THEREOF FOR THE TREATMENT OF HYPERTRIGLYCERIDEMIA

No-Receipt date 2014-02506 - 26/08/2014
No-Filing date 20140401725 - 26/08/2014
No-Granting date 3051303.B2 - 29/10/2014
No-EPO application date 01900978.6 - 09/01/2001
No-EPO granting date 1246638 - 30/07/2014
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 10/2014 - 21/11/2014
Expiration date 10/01/2021
Kind of title Amended European Patent Validation
Legal status NOT VALID
Priorities US175365 P10/01/2000/US
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
A61P 3/06
A61K 38/22
A61K 38/22
A61K 38/22
A61K 31/40
A61K 31/22
A61K 31/20
A61K 38/22
A61K 38/22
A61K 31/365

Related Documents

Related Titles
TypeMaster titleRelated title
[ADD] 20040403823

Owners
CodeFirstnameSurnameAddressTownZIPCountry
453646 AMYLIN PHARMACEUTICALS, LLC 9360 TOWNE CENTRE DRIVESAN DIEGO, CA 92121 UNITED STATES OF AMERICA (USA)
471523 ASTRAZENECA PHARMACEUTICALS LP 1800 CONCORD PIKE,WILMINGTON DELAWARE, U.S.A. UNITED STATES OF AMERICA (USA)

Inventors
CodeFirstnameSurname
1340148 KOLTERMAN, ORVILLE, GENE
1340149 YOUNG, ANDREW, A.

Representatives
CodeFirstnameSurnameAddressTownZip
1349ELENIPAPAKONSTANTINOUKOUMPARI 2ATHINA (ATTIKIS)10674

Contact
CodeFirstnameSurnameAddressTownZipCountry
4007ELENIPAPAKONSTANTINOUKOUMPARI 2ATHINA (ATTIKIS)10674 GREECE

Owners History

Title Instruments
DateOperationDescreption
8/11/2017 12:00:00 AMΈκπτωση Κύριων Τίτλων (79602) ΕΚΠΤΩΣΕΙΣ 07 / 2017 Αρ. Πρωτ. ΓΔ 1373 / 11-08-2017

Payments history 16 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015
 
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).